26 results
424B4
RNAZ
TransCode Therapeutics Inc
19 Jan 24
Prospectus supplement with pricing info
9:57pm
, including:
regulators, IRBs, or ethics committees may not authorize us or our investigators to commence a clinical trial or conduct a clinical trial … are not substantially reduced during delays;
we may elect to, or regulators, IRBs, Data Safety Monitoring Boards, or DSMBs, or ethics committees may require that we
PRE 14A
q8sfvfuop6iucx1pe89
31 Mar 23
Preliminary proxy
4:17pm
DRS
39gq2v
29 Jul 22
Draft registration statement
12:00am
DEF 14A
p7s5ib
2 May 22
Definitive proxy
4:02pm
10-K
h7239 x0zdgpq59o4
31 Mar 22
Annual report
11:19am
10-Q
pcp6aro0rsx
23 Aug 21
Quarterly report
4:53pm
424B4
3h84a2x ftn8
9 Jul 21
Prospectus supplement with pricing info
5:22pm